Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Glenmark Introduces Higher Strength Of Fabiflu To Reduce Pill Burden Of Covid-19 Treatment

The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day

Photo Credit : Shutterstock

Glenmark Pharmaceuticals will introduce a 400 mg version of oral anti-viral FabiFlu for the treatment of mild to moderate Covid-19 in India.

The higher strength will improve patient compliance and experience by effectively reducing the number of tablets that patients require per day, the pharma major said on Thursday.

A higher pill burden has been associated with lower adherence to therapy, the latter affecting viral suppression and overall treatment outcomes. Reducing the pill burden has been a demand from doctors and patients to enable adherence.

"Introducing this higher strength of FabiFlu is in line with these efforts to ensure a smoother experience for patients by reducing their daily pill burden," said Monika Tandon, Vice President and Head of Clinical Development, Global Specialty and Branded Portfolio.

Glenmark said it has also commenced a post-marketing surveillance study on FabiFlu to closely monitor the efficacy and safety of the drug in a large pool of patients prescribed with the oral antiviral Favipiravir as part of an open-label, multi-centre, single-arm study.

The company is also conducting another phase three clinical trial to evaluate the efficacy of two anti-virals drugs Favipiravir and Umifenovir as a combination therapy in moderate hospitalised adult Covid-19 patients in India. 

(ANI)

Disclaimer: The views expressed in the article above are those of the authors' and do not necessarily represent or reflect the views of this publishing house. Unless otherwise noted, the author is writing in his/her personal capacity. They are not intended and should not be thought to represent official ideas, attitudes, or policies of any agency or institution.


ANI

ANI

More From The Author >>